Abstract:Objective This meta-analysis attempted to derive pooled estimates for the associations between various cardiovascular-renal disorders and the deletion/insertion (D/I) polymorphism of the angiotensin converting enzyme (ACE) gene.Methods Case-control studies were combined, using the Mantel-Haenszel approach. Joint P values for continuous variables were calculated by Stouffer's method. Continuous measurements reported in different units were expressed on a percentage scale using the within-study mean of the II genotype as the denominator.Results The computerized database used for this analysis included 145 reports with an overall sample size of 49 959 subjects. Overall, possession of the D allele was associated with an increased risk of atherosclerotic and renal microvascular complications. In comparison with the II reference group, the excess risk in DD homozygotes (P < 0.001) was 32% for coronary heart disease (CHD; 30 studies), 45% for myocardial infarction (20 studies), 94% for stroke (five studies) and 56% for diabetic nephropathy (11 studies). The corresponding risk in DI heterozygotes amounted to 11% (P = 0.02), 13% (P = 0.02), 22% (P = 0.10) and 40% (P < 0.001), respectively. Hypertension (23 studies), left ventricular hypertrophy (five studies), hypertrophic or dilated cardiomyopathy (eight studies) and diabetic retinopathy (two studies) were not related to the DI polymorphism. Publication bias was observed for CHD, myocardial infarction and microvascular nephropathy, but not hypertension. In studies with DNA amplification in the presence of insertion-specific primers, the risk associated with the DD genotype increased to 150% [95% confidence interval (CI) 76-256; four studies] for diabetic nephropathy, but decreased to 12% (95% CI -3 to 28; seven studies) for CHD and 14% (95% CI -6 to 37; four studies) for myocardial infarction. On the other hand, the pooled odds ratios did not materially change if the metaanalysis was limited to articles published in journals with an impact factor of at least 4. Furthermore, compared with the II control group, the circulating ACE levels (29 studies) were raised 58 and 31% (P < 0.001) in DD and DI subjects, respectively. In contrast, plasma renin (10 studies), systolic and diastolic blood pressure (46 studies) and body mass index (30 studies) were not associated with the D allele.Conclusion The D allele is not associated with hypertension, but behaves as a marker of atherosclerotic cardiovascular complications and diabetic nephropathy. These associations do not necessarily imply a causal relationship and may have been inflated by publication bias. Nevertheless, their possible therapeutic implications may be subject to further investigation in prospective (intervention) studies. (C) Rapid Science Publishers ISSN 0263-6352.

Impacts of ACE insertion/deletion variant on cardiometabolic risk factors, premature coronary artery disease, and severity of coronary lesions

Association of the Genetic Polymorphism of Angiotensin-Converting Enzyme and Idiopathic Dilated Cardiomyopathy

The Deletion/insertion Polymorphism of the Angiotensin Converting Enzyme Gene and Cardiovascular-Renal Risk.

Angiotensin-converting Enzyme Gene Deletion Allele Increases the Risk of Left Ventricular Hypertrophy: Evidence from a Meta-Analysis

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis.

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis

Angiotensin-converting Enzyme Insertion/deletion Polymorphism Contributes to Ischemic Stroke Risk: a Meta-Analysis of 50 Case-Control Studies.

Polymorphism of angiotensin converting enzyme in Han populations and its relevance to the severity of coronary atherosclerosis]

Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis.

Angiotensin-Converting Enzyme I/D and Alpha-Adducin Gly460trp Polymorphisms - from Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome

Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis

Advance of ACE I/D Gene Polymorphisms in Cardiovascular Disease

Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome Polymorphisms : FromGly 460 Trp-Adducin α and I / DAngiotensin-Converting Enzyme

The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection

Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus

[Clinical Study of the Impact of ACE I/D Gene Variation on the Clinical Parameters of Patients with Polycystic Ovary Syndrome]

I/D polymorphism of ACE and risk of diabetes-related end-stage renal disease: a systematic review and meta-analysis.

Angiotensin-Converting Enzyme I/D Polymorphism is Associated with Copd Risk in Asian Population: Evidence from A Meta-Analysis

Carotid Remodeling of Hypertensive Subjects and Polymorphism of the Angiotensin-Converting Enzyme Gene.

Association Study of Angiotensin Converting Enzyme Polymorphism with Myocardial Infarction in Chinese

Cardiovascular and Metabolic Phenotypes in Relation to the ADRA2B Insertion/deletion Polymorphism in a Chinese Population